Drugs / MLYAAT-1002®
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06891924 | Mar → Jun 2025 overdue | skin atrophy | Botanee Group Co., Ltd. | Not yet recruiting | No outcome recorded |
| — | NCT06188338 | Nov 2023 → Jan 2024 | skin disorder | Botanee Group Co., Ltd. | Completed | No outcome recorded |
| — | NCT06140628 | Sep → Nov 2023 | skin disorder | Botanee Group Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MLYAAT-1002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06891924 ↗ |
| Route | Topical | “apply one pump of the formulation to the treated side of the face in the morning and evening, respectively” NCT06140628 ↗ |